247 related articles for article (PubMed ID: 6345744)
1. Systems validation for parenteral clinical drugs--application to R&D and QC laboratories.
Tetzlaff RF
J Parenter Sci Technol; 1983; 37(2):45-50. PubMed ID: 6345744
[No Abstract] [Full Text] [Related]
2. [Guidelines for introducing new drugs for medical use in Poland and control of their quality].
Danysz A
Pol Tyg Lek; 1984 Dec 17-31; 39(51-52):1673-4. PubMed ID: 6522321
[No Abstract] [Full Text] [Related]
3. [Standardization as a basis planning and administration in drug industry and pharmacy (II)].
Wagler M
Pharm Prax; 1970; 7():151-3. PubMed ID: 5469874
[No Abstract] [Full Text] [Related]
4. WHO Expert Committee on Specifications for Pharmaceutical Preparations. Forty-first report.
World Health Organization
World Health Organ Tech Rep Ser; 2007; (943):1-156. PubMed ID: 17621973
[TBL] [Abstract][Full Text] [Related]
5. Quality by design, process analytical technology, GMP and regulatory affairs.
Çelik M
Pharm Dev Technol; 2018 Jul; 23(6):553. PubMed ID: 29785887
[No Abstract] [Full Text] [Related]
6. [Basic trends in research on the standardization and control of drugs].
Smirnov MI
Farm Zh; 1977; 32(4):31-5. PubMed ID: 913544
[No Abstract] [Full Text] [Related]
7. [International interdependence of new German pharmaceutical laws].
Hasskarl H
Monogr Gesamtgeb Psychiatr Psychiatry Ser; 1978; 19():61-77. PubMed ID: 714040
[No Abstract] [Full Text] [Related]
8. Enforcement of the current good manufacturing practices for solid oral dosage forms after United States v. Barr Laboratories.
Jimenez FA
Food Drug Law J; 1997; 52(1):67-82. PubMed ID: 10346711
[No Abstract] [Full Text] [Related]
9. Good manufacturing practices and clinical supplies.
Levchuk JW
J Parenter Sci Technol; 1991; 45(3):152-5. PubMed ID: 1886044
[TBL] [Abstract][Full Text] [Related]
10. Top ten hot topics in parenteral science and technology.
Akers MJ; Nail SL; Saffell-Clemmer W
PDA J Pharm Sci Technol; 2007; 61(5):337-61. PubMed ID: 18047174
[TBL] [Abstract][Full Text] [Related]
11. Clinical investigation of new drugs.
N Engl J Med; 1967 Nov; 277(21):1148-9. PubMed ID: 4861565
[No Abstract] [Full Text] [Related]
12. WHO Expert Committee on Specifications for Pharmaceutical Preparations.
World Health Organ Tech Rep Ser; 2008; (948):1-138. PubMed ID: 18557474
[TBL] [Abstract][Full Text] [Related]
13. [Technological and raw-material factors that determine drug quality and the efficiency of their production].
Muravev IO
Farm Zh; 1977; 32(4):18-21. PubMed ID: 913539
[No Abstract] [Full Text] [Related]
14. Validation of tangential flow filtration (TFF) systems.
Michaels SL
J Parenter Sci Technol; 1991; 45(5):218-23. PubMed ID: 1753311
[No Abstract] [Full Text] [Related]
15. Response to the applicability of proposed large volume parenteral regulations to small volume parenteral drug products.
Bull Parenter Drug Assoc; 1976; 30(6):265-79. PubMed ID: 1000103
[No Abstract] [Full Text] [Related]
16. PDA presentation at FDA Open Conference on Sterile Drug Manufacturing. Parenteral Drug Association.
J Pharm Sci Technol; 1994; 48(1):4-6. PubMed ID: 8004417
[No Abstract] [Full Text] [Related]
17. [Information systems for phase III and IV clinical trials].
Alamercery Y; Begaud ; Chastang ; Derzko ; Dupuis Y; Gomeni R; Go L; Lemarie ; Mery ; Wartelle
J Pharmacol; 1986; 17 Suppl 1():12-8. PubMed ID: 3747536
[No Abstract] [Full Text] [Related]
18. [Scientific achievements in the field of pharmaceutical analysis and the ways of improving the control of drug quality in the 10th Five-Year Plan].
Tentsova AI; Senov PL; Belikov VG
Farm Zh; 1977; 32(4):13-8. PubMed ID: 913538
[No Abstract] [Full Text] [Related]
19. [Clinical testing of drugs].
Begemann H
Med Klin; 1973 May; 68(18):569-71. PubMed ID: 4576603
[No Abstract] [Full Text] [Related]
20. The brand name versus generic controversy: Is there a segment of the pharmaceutical industry that produces drugs of higher quality?
Marsh DA; Hoar ME
Contemp Pharm Pract; 1982; 5(2):130-5. PubMed ID: 10317245
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
